Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results

Click here to go back to your search results.

Lung Cancer treatment details. Chemotherapy. Yonsei University College of Medicine, Seoul, Korea

Survival: 5.2 months
Toxicity Grade: 3
Treatments: Chemotherapy
Country: Korea
City/State/Province: Seoul
Hospital: Yonsei University College of Medicine
Journal: Link
Date: 6/2007

Patients: This phase II study involved 21 patients with stage IIIB/IV recurrent or metastatic non-small-cell lung cancer. All had received prior chemotherapy including gefitinib. The median age was 56 years old. Eleven of the patients had never smoked.

Treatment: All patients were treated with the chemotherapy drug erlotinib.

Toxicity: Grade 3 skin rash and vomiting were reported in one and two patients, respectively. The most common adverse event was grade 1/2 skin rash.

Results: The median overall survival was 158 days (5.2 months).

Correspondence: Dr. Joo Hang Kim

E-mail to a Friend Email Physician More Information